Neovacs

Neovacs is a biotechnology company established in 1993 as a spin-off from Pierre & Marie Curie University in Paris, founded by Professor Daniel Zagury, a prominent immunologist. The company specializes in developing therapeutic vaccines, known as "Kinoids," aimed at treating various conditions, including autoimmune diseases, allergies, and cancer. Neovacs is recognized for its innovative approach to vaccine development, focusing on creating therapeutic vaccines that stimulate a robust natural polyclonal antibody response, in contrast to conventional treatments that utilize monoclonal antibodies. With a comprehensive patent portfolio, Neovacs is at the forefront of advancing novel therapeutic solutions to combat diseases related to cytokines and immunosuppressive viral proteins.